For: | Marinaki S, Boletis JN, Sakellariou S, Delladetsima IK. Hepatitis C in hemodialysis patients. World J Hepatol 2015; 7(3): 548-558 [PMID: PMC4381177 DOI: 10.4254/wjh.v7.i3.548] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v7/i3/548.htm |
Number | Citing Articles |
1 |
Manoochehr Makvandi. Update on occult hepatitis B virus infection. World Journal of Gastroenterology 2016; 22(39): 8720-8734 doi: 10.3748/wjg.v22.i39.8720
|
2 |
Elizabeth Buganza-Torio, Karen Elizabeth Doucette. Management of Viral Hepatitis in Solid Organ Transplant Recipients. Infectious Disease Clinics of North America 2018; 32(3): 635 doi: 10.1016/j.idc.2018.04.010
|
3 |
Che-Pin Chang, Yuan-Chih Su, Mei-Chen Lin, Sheng-Teng Huang. Chinese Herbal Medicine Ameliorated the Development of Chronic Kidney Disease in Patients with Chronic Hepatitis C: A Retrospective Population-Based Cohort Study. Evidence-Based Complementary and Alternative Medicine 2019; 2019: 1 doi: 10.1155/2019/5319456
|
4 |
Ruzica Lukic, Nevena Gajovic, Ivan Jovanovic, Milena Jurisevic, Zeljko Mijailovic, Veljko Maric, Biljana Popovska Jovicic, Nebojsa Arsenijevic. Potential Hepatoprotective Role of Galectin-3 during HCV Infection in End-Stage Renal Disease Patients. Disease Markers 2017; 2017: 1 doi: 10.1155/2017/6275987
|
5 |
Marco Ladino, Fernando Pedraza, David Roth. Opportunities for treatment of the hepatitis C virus-infected patient with chronic kidney disease. World Journal of Hepatology 2017; 9(19): 833-839 doi: 10.4254/wjh.v9.i19.833
|
6 |
Elena Laura Iliescu, Adriana Mercan-Stanciu, Letitia Toma. Safety and efficacy of direct-acting antivirals for chronic hepatitis C in patients with chronic kidney disease. BMC Nephrology 2020; 21(1) doi: 10.1186/s12882-020-1687-1
|
7 |
Elmukhtar Habas, Aml Habas, Mohamed Elgamal, Bara Shraim, Moaz Moursi, Ayman Ibrahim, Mohamed Danjuma, Abdel-Naser Elzouki. Common complications of hemodialysis: A clinical review. Ibnosina Journal of Medicine and Biomedical Sciences 2021; 13(04): 161 doi: 10.4103/ijmbs.ijmbs_62_21
|
8 |
Rashmi K S, Faiza Samreen, Anjana Gopi, Swati Jain. SEROPREVALENCE OF HCV INFECTION AMONG PATIENTS IN A TERTIARY CARE HOSPITAL IN BANGALORE. Journal of Evolution of Medical and Dental Sciences 2017; 6(31): 2541 doi: 10.14260/Jemds/2017/550
|
9 |
Engy A. Mogahed, Hanan Abdelaziz, Heba Helmy, Haytham Ghita, Mohamed A. Abdel Mawla, Fetouh Hassanin, Fatina I. Fadel, Hanaa El-Karaksy. Safety and Efficacy of Pegylated Interferon Alpha-2b Monotherapy in Hepatitis C Virus-Infected Children with End-Stage Renal Disease on Hemodialysis. Journal of Interferon & Cytokine Research 2016; 36(12): 681 doi: 10.1089/jir.2016.0019
|
10 |
Livia Melo Villar, Helena Medina Cruz, Moyra Machado Portilho, Jakeline Ribeiro Barbosa, Ana Carolina Fonseca da Mendonça, Geane Lopes Flores. Public Health - Emerging and Re-emerging Issues. 2018; doi: 10.5772/intechopen.79174
|
11 |
Karl Lewalter, Sebastian Lemmen. Praktische Krankenhaushygiene und Umweltschutz. 2016; : 1 doi: 10.1007/978-3-642-41169-4_28-1
|
12 |
Nikolaos Papadopoulos, Ioannis Griveas, Eirini Sveroni, Vasiliki Argiana, Antonios Kalliaropoulos, Beatriz Martinez-Gonzalez, Melanie Deutsch. HCV viraemia in anti-HCV-negative haemodialysis patients: Do we need HCV RNA detection test?. The International Journal of Artificial Organs 2018; 41(3): 168 doi: 10.1177/0391398817752326
|
13 |
Gde Somayana, Komang Agus Wira Nugraha. Hepatitis C - Recent Advances. 2023; doi: 10.5772/intechopen.1001052
|
14 |
Ryoichi Miyazaki, Kyoko Miyagi, Rika Kawamura. Treatment of hepatitis C virus infections in hemodialysis patients at our hospital and future prospects. Nihon Toseki Igakkai Zasshi 2017; 50(5): 281 doi: 10.4009/jsdt.50.281
|
15 |
Tatjana Vilibic-Cavlek, Jasmina Kucinar, Bernard Kaic, Maja Vilibic, Nenad Pandak, Ljubo Barbic, Vladimir Stevanovic, Jasmina Vranes. Epidemiology of hepatitis C in Croatia in the European context. World Journal of Gastroenterology 2015; 21(32): 9476-9493 doi: 10.3748/wjg.v21.i32.9476
|
16 |
Gaofeng Cai, Hongjie Zheng, Lan Luo, Zhengting Wang, Zhenggang Jiang, Shuangfei Xu, Huakun Lv, Yongdi Chen, Biao Zhou, Chonggao Hu. Factors Correlating to the Development of Hepatitis C Virus Infection in Hemodialysis Patients—Findings Mainly from Asiatic Populations: A Systematic Review and Meta-Analysis. International Journal of Environmental Research and Public Health 2019; 16(8): 1453 doi: 10.3390/ijerph16081453
|
17 |
Karl Lewalter, Sebastian Lemmen. Praktische Krankenhaushygiene und Umweltschutz. 2018; : 421 doi: 10.1007/978-3-642-40600-3_28
|
18 |
S. Mhalla, R. Hammoud, A. Frih, Y. Kadri, A. El Argoubi, M. Elmay, M. Mastouri. Prevalence and risk factors of hepatitis B and C among hemodialysis patients in Tunisia. Médecine et Maladies Infectieuses 2018; 48(3): 175 doi: 10.1016/j.medmal.2017.11.006
|
19 |
K. Lewalter, S. Lemmen. Repetitorium Krankenhaushygiene, hygienebeauftragter Arzt und ABS-beauftragter Arzt. 2017; : 499 doi: 10.1007/978-3-662-54000-8_26
|
20 |
L. S. Aho-Glélé, H. Giraudon, K. Astruc, Z. Soltani, A. Lefebvre, P. Pothier, J. B. Bour, C. Manoha. Investigation of a Case of Genotype 5a Hepatitis C Virus Transmission in a French Hemodialysis Unit Using Epidemiologic Data and Deep Sequencing. Infection Control & Hospital Epidemiology 2016; 37(2): 134 doi: 10.1017/ice.2015.263
|
21 |
Javier A. Pagan, Marco Ladino, David Roth. End-Stage Renal Disease and Treatment of Hepatitis C Virus Infection. Current Hepatology Reports 2018; 17(1): 78 doi: 10.1007/s11901-018-0387-9
|
22 |
Ebtisam Boushi, Khaled Cheha, Noha Hedar, Rasha Almokdad, Mohammed Waleed Alassi, Ameer Kakaje. Sofosbuvir/ledipasvir safety and efficacy for HCV patients with haemodialysis and liver cirrhosis: a small retrospective study. Egyptian Liver Journal 2021; 11(1) doi: 10.1186/s43066-021-00150-3
|
23 |
Adriana Dejman, Marco A. Ladino, David Roth. Treatment and management options for the hepatitis C virus infected kidney transplant candidate. Hemodialysis International 2018; 22(S1) doi: 10.1111/hdi.12646
|
24 |
Claudia Cottone, Kalyan Ram Bhamidimarri. Evaluating CKD/ESRD patient with hepatitis C infection: How to interpret diagnostic testing and assess liver injury. Seminars in Dialysis 2019; 32(2): 119 doi: 10.1111/sdi.12760
|
25 |
Ryoichi Miyazaki, Kyoko Miyagi. Effect and Safety of Daclatasvir‐Asunaprevir Combination Therapy for Chronic Hepatitis C Virus Genotype 1b ‐Infected Patients on Hemodialysis. Therapeutic Apheresis and Dialysis 2016; 20(5): 462 doi: 10.1111/1744-9987.12407
|
26 |
Anna Maruyama, Nilufar Partovi, Eric M. Yoshida, Siegfried R. Erb, Vladimir Marquez Azalgara, Trana Hussaini. A review of direct-acting antivirals for the treatment of hepatitis C in patients with advanced chronic kidney disease. Nephrology Dialysis Transplantation 2015; : gfv361 doi: 10.1093/ndt/gfv361
|
27 |
A. Ferreira-Gonzalez. Diagnostic Molecular Pathology. 2017; : 485 doi: 10.1016/B978-0-12-800886-7.00038-8
|
28 |
Bengu Tatar, Sukran Kose, Emel Pala, Erhan Tatar. Inflammatory Biomarkers and Liver Histopathology in Non-Uremic and Uremic Chronic Hepatitis C Patients. Acta Medica (Hradec Kralove, Czech Republic) 2017; 60(2): 71 doi: 10.14712/18059694.2017.96
|
29 |
Ioana Adela Ratiu, Adelina Mihaescu, Nicu Olariu, Cristian Adrian Ratiu, Bako Gabriel Cristian, Anamaria Ratiu, Mirela Indries, Simona Fratila, Danut Dejeu, Alin Teusdea, Mariana Ganea, Corina Moisa, Luciana Marc. Hepatitis C Virus Infection in Hemodialysis Patients in the Era of Direct-Acting Antiviral Treatment: Observational Study and Narrative Review. Medicina 2024; 60(12): 2093 doi: 10.3390/medicina60122093
|
30 |
Jakeline Ribeiro Barbosa, Vanessa Faria Cortes, Moyra Machado Portilho, Juliana Custódio Miguel, Vanessa Alves Marques, Cristianne Sousa Bezerra, Natalia Vasconcelos de Souza, Danielle Malta Lima, Jeová Keny Baima Colares, Lia Laura Lewis-Ximenez, Elisabeth Lampe, Livia Melo Villar. Performance of point of care assays for hepatitis B and C viruses in chronic kidney disease patients. Journal of Clinical Pathology 2018; 71(10): 879 doi: 10.1136/jclinpath-2018-205024
|
31 |
Ali Kargar Kheirabad, Fahime Bahri, Mohammad Kargar, Iman Ghasemzadeh. Hepatitis C and G Virus Infection Prevalence Among Hemodialysis Patients and Associated Risk Factors in the Hormozgan Province of Southern Iran. Hepatitis Monthly 2016; 16(10) doi: 10.5812/hepatmon.40375
|
32 |
Marzieh Jamalidoust, Maryam Eskandari, Mazyar Ziyaeyan. Prevalence of Hepatitis C Infection and its Genotypes in Suspected Hemodialysis Patients, Southwest of Iran. Jundishapur Journal of Microbiology 2021; 14(11) doi: 10.5812/jjm.118591
|
33 |
Marco Ladino, Fernando Pedraza, David Roth. Hepatitis C Virus Infection in Chronic Kidney Disease. Journal of the American Society of Nephrology 2016; 27(8): 2238 doi: 10.1681/ASN.2016010030
|
34 |
Kalyan Ram Bhamidimarri, Paul Martin. Finally, safe and effective treatment options for hepatitis C in hemodialysis patients. Journal of Hepatology 2016; 65(1): 7 doi: 10.1016/j.jhep.2016.04.003
|
35 |
Sammy Saab, Melissa A. Jimenez, Sherona N. Bau, Gina Choi, Francisco A. Durazo, Mohammed M. El-Kabany, Steven-Huy B. Han, Ronald W. Busuttil. Use of Sofosbuvir-Based Treatment of Chronic Hepatitis C in Liver Transplant Recipients on Hemodialysis. Journal of Clinical Gastroenterology 2017; 51(2): 167 doi: 10.1097/MCG.0000000000000640
|
36 |
Raoul Kenfack-Momo, Marceline Djuidje Ngounoue, Sebastien Kenmoe, Guy Roussel Takuissu, Jean Thierry Ebogo-Belobo, Cyprien Kengne-Ndé, Donatien Serge Mbaga, Elisabeth Zeuko’o Menkem, Robertine Lontuo Fogang, Serges Tchatchouang, Juliette Laure Ndzie Ondigui, Ginette Irma Kame-Ngasse, Josiane Kenfack-Zanguim, Jeannette Nina Magoudjou-Pekam, Arnol Bowo-Ngandji, Maimouna Mahamat, Seraphine Nkie Esemu, Lucy Ndip, Richard Njouom, Chen-Hua Liu. Global epidemiology of hepatitis C virus in dialysis patients: A systematic review and meta-analysis. PLOS ONE 2024; 19(2): e0284169 doi: 10.1371/journal.pone.0284169
|
37 |
Matías J. Pereson, Alfredo P. Martínez, Katia Isaac, Gustavo Laham, Ezequiel Ridruejo, Gabriel H. Garcia, Diego M. Flichman, Federico A. Di Lello. Seroprevalence of hepatitis B, hepatitis C and HIV infection among patients undergoing haemodialysis in Buenos Aires, Argentina.
Journal of Medical Microbiology
2021; 70(1) doi: 10.1099/jmm.0.001278
|
38 |
Haruki Uojima, Shuzo Kobayashi, Hisashi Hidaka, Shuichi Matsumoto, Takayasu Ohtake, Takeshi Kinbara, Machiko Oka, Yasuhiro Yamanouchi, Takehiko Kunieda, Hiroki Yamanoue, Takayuki Kanemaru, Kazuhiko Tsutsumi, Tomoaki Fujikawa, Ji Hyun Sung, Makoto Kako. Virological response to daclatasvir and asunaprevir combination therapy for chronic hepatitis C virus genotype 1b infection in dialysis patients: a prospective, multicenter study. Renal Replacement Therapy 2017; 3(1) doi: 10.1186/s41100-016-0091-6
|
39 |
Aude Desnoyer, Dan Pospai, Minh Patrick Lê, Anne Gervais, Alexandra Heurgué-Berlot, Achour Laradi, Stanislas Harent, Adriana Pinto, Dominique Salmon, Sophie Hillaire, Hélène Fontaine, David Zucman, Anne-Marie Simonpoli, Patrice Muret, Lucile Larrouy, Brigitte Bernard Chabert, Diane Descamps, Yazdan Yazdanpanah, Gilles Peytavin. Pharmacokinetics, safety and efficacy of a full dose sofosbuvir-based regimen given daily in hemodialysis patients with chronic hepatitis C. Journal of Hepatology 2016; 65(1): 40 doi: 10.1016/j.jhep.2016.02.044
|
40 |
Natasha Silva Constancio, Maria Lucia Gomes Ferraz, Carmen Tzanno Branco Martins, Angiolina Campos Kraychete, Paulo Lisboa Bitencourt, Marcelo Mazza do Nascimento. Hepatitis C in Hemodialysis Units: diagnosis and therapeutic approach. Brazilian Journal of Nephrology 2019; 41(4): 539 doi: 10.1590/2175-8239-jbn-2018-0177
|
41 |
Trodia Zitha, Chien-Yu Chen, Hatim Mudawi, Waleed Hussein, Maowia Mukhtar, Mazin Shigidi, Mohamed Elamin Awad Yousif, Mohammed Ahmed Ali, Dieter Glebe, Anna Kramvis. Molecular characterization and genotyping of hepatitis C virus from Sudanese end-stage renal disease patients on haemodialysis. BMC Infectious Diseases 2022; 22(1) doi: 10.1186/s12879-022-07833-1
|
42 |
Cristina Gómez-Gutiérrez, Norberto C. Chávez-Tapia, Guadalupe Ponciano-Rodríguez, Misael Uribe, Nahum Méndez-Sánchez. Prevalence of hepatitis C virus infection among patients undergoing haemodialysis in Latin America. Annals of Hepatology 2015; 14(6): 807 doi: 10.5604/16652681.1171751
|
43 |
Rita C.F. Tavares, Ana C.C.A. Feldner, João R.R. Pinho, Silvia N.O. Uehara, Christini T. Emori, Roberto J. Carvalho-Filho, Ivonete S.S. Silva, Rúbia A.F. Santana, Vanessa F.D. de Castro, Gregório T. F. Castoli, Charliana U. Cristovão, Maria L.C.G. Ferraz. Prevalence of naturally occurring protease inhibitor resistance-associated variants in hemodialysis and renal transplant patients with hepatitis C virus infection. European Journal of Gastroenterology & Hepatology 2017; 29(7): 754 doi: 10.1097/MEG.0000000000000866
|